Related Experiment Video
Updated: May 28, 2026

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein
Published on: September 29, 2021
Low-level laser irradiation, cyclooxygenase-2 (COX-2) expression and necrosis of random skin flaps in rats
Ivaldo Esteves Junior1, Igor B Masson, Celina T F Oshima
1Department of Surgery, Division of Operative Technique and Experimental Surgery, Federal University of São Paulo - UNIFESP, São Paulo, SP, Brazil.
Abstract:
Skin flaps are still a matter of concern among surgeons, as failures can occur leading to flap necrosis. However, low-level laser irradiation has been reported as an effective tool to improve the viability of ischemic flaps, yet its mechanisms of action remain unclear. We investigated the effect of low-level laser irradiation on the viability of random skin flaps in rats and determined COX-2 expression in the flap pedicle. The study animals comprised 24 EPM-1 Wistar rats which were randomly allocated into three equal groups. A cranially based dorsal random skin flap measuring 10 × 4 cm was created in all the animals. In one group, laser irradiation was simulated (sham group), and in the other two groups the animals were irradiated at 12 points with 0.29 J at 20 mW (energy density 10.36 J/cm(2), irradiance 0.71 W/cm(2)), or with 7.3 J at 100 mW (energy density 260.7 J/cm(2), irradiance 3.57 W/cm(2)). These procedures were applied to the cranial half of the flap immediately after surgery and were repeated on days 2 and 5 after surgery. The percentage necrotic area was determined on day 7 after surgery by the paper template method. The immunohistochemical expression of COX-2 in the samples was given scores from 0 to 3. The necrotic area was smaller in group irradiated at 7.3 J compared to sham-treated group and to the group irradiated at 0.29 J (P < 0.05); there was no difference between the sham-treated group and group irradiated at 0.29 J. COX-2 expression was lower in the group irradiated at 7.3 J than in the sham-treated group and the group irradiated at 0.29 J (P < 0.001). Low-level laser therapy was effective in decreasing random skin flap necrosis in rats using a laser energy of 7.30 J per point. Laser irradiation also decreased the expression of COX-2 in the flap pedicle.
Insights
Low-level laser therapy effectively reduced skin flap necrosis in rats by decreasing cyclooxygenase-2 (COX-2) expression. This study highlights laser irradiation as a promising method to improve flap viability in surgical procedures.
Area of Science:
- Regenerative Medicine
- Biomedical Engineering
- Surgical Innovation
Background:
- Skin flap necrosis remains a significant surgical complication.
- Low-level laser irradiation (LLLI) shows potential for improving ischemic flap viability, but mechanisms are unclear.
- Cyclooxygenase-2 (COX-2) is implicated in inflammatory and healing processes relevant to flap survival.
Purpose of the Study:
- To investigate the efficacy of LLLI in reducing random skin flap necrosis in a rat model.
- To determine the effect of LLLI on COX-2 expression in the flap pedicle.
- To elucidate the potential mechanisms by which LLLI enhances flap viability.
Main Methods:
- 24 Wistar rats underwent random skin flap creation and were divided into three groups: sham, LLLI (0.29 J), and LLLI (7.3 J).
- LLLI was applied immediately post-surgery and repeated on days 2 and 5.
- Necrotic area was measured on day 7, and COX-2 expression was assessed immunohistochemically.
Main Results:
- The group treated with 7.3 J LLLI exhibited significantly smaller necrotic areas compared to sham and 0.29 J groups (P < 0.05).
- COX-2 expression was significantly lower in the 7.3 J LLLI group compared to sham and 0.29 J groups (P < 0.001).
- No significant difference in necrosis was observed between sham and 0.29 J groups.
Conclusions:
- LLLI, particularly at 7.3 J per point, is effective in reducing random skin flap necrosis in rats.
- LLLI at this dosage also decreases COX-2 expression in the flap pedicle.
- These findings suggest LLLI may improve flap survival through modulation of inflammatory pathways involving COX-2.
